First-line management of metastatic non-small cell lung cancer: An Indian perspective

Lung cancer has been the most common cancer in the world for several decades. The non-small cell lung cancer (NSCLC) constitutes approximately about 80% of the total cases of lung cancer. Therapeutic interventions in NSCLC have shifted to the target-based approach from histology-based approach, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghadyalpatil, Nikhil Suresh, Pandey, Avinash, Krishnamani, Iyer, Srinivas, Chilukuri, Rafiq, Shabnam J., Hingmire, Sachin S., Maturu, Nagarjuna, Reddy, Ragotham, Kumar, Kiran K., Sreekanth, K., Gurram, Bharath Chandra, Parikh, P. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6498710/
https://www.ncbi.nlm.nih.gov/pubmed/31069181
http://dx.doi.org/10.4103/sajc.sajc_294_18
Descripción
Sumario:Lung cancer has been the most common cancer in the world for several decades. The non-small cell lung cancer (NSCLC) constitutes approximately about 80% of the total cases of lung cancer. Therapeutic interventions in NSCLC have shifted to the target-based approach from histology-based approach, and this has completely changed the face of the management of NSCLC. Developing countries, such as India, have very limited data compiled about the prevalence and treatment practices of lung cancer, despite a large burden of the disease. However, in recent times, there has been a lot of data generated in this regard. This article is an attempt to collate and shine light on the available data for the first-line treatment of NSCLC in India keeping in mind the current standards of care in this area.

Ejemplares similares